Real-world challenges associated with the use of four common systemic glucocorticoids in a United States IgAN cohort
ObjectivesTo understand the difference in adverse events (AEs), healthcare resource utilization (HCRU), and kidney failure rates in immunoglobulin A nephropathy (IgAN) patients who initiated systemic glucocorticoid (SGC) treatment compared with those who did not.MethodsThe overall cohort was selecte...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Nephrology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fneph.2025.1574239/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|